The Alex Waters Podcast
Stephen Bright is a Psychologist, Ethnopharmacologist and Founding Member and Vice-President of PRISM (Psychedelic Research in Science & Medicine), an independent non-profit research organization on Psychedelics. We dived into the current state of psychedelic research in Australia and talked about the first MDMA assisted clinical trials about to start in Perth to treat PTSD & Depression. Links: https://www.prism.org.au/tag/stephen-bright/ [https://www.prism.org.au/tag/stephen-bright/] https://www.ecu.edu.au/schools/medical-and-health-sciences/our-staff/profiles/senior-lecturers/dr-stephen-bright [https://www.ecu.edu.au/schools/medical-and-health-sciences/our-staff/profiles/senior-lecturers/dr-stephen-bright] https://twitter.com/stephenjbright?lang=en [https://twitter.com/stephenjbright?lang=en] Episode Notes: 4:22 Current Updates on Psychedelics Research in Australia 6:11 The First successful trial of Psilocybin in Australia 15:08 Interesting facts on young people and drugs 31:12 Mystical Experiences from Psychoactive drugs 39:10 Psychedelic drugs are neutral 45:30 Eye-opening experiences in Psychedelic studies 50:10 Why were Psilocybin mushrooms banned? 52:33 Estimated costs to produce and access Psychedelics
20 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de The Alex Waters Podcast!